SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?


To: Robert Dydo who wrote (349)1/22/1999 12:14:00 AM
From: hsg  Read Replies (1) | Respond to of 572
 
Good points. The Olympus deal...was it a good one in retrospect? Still, revenue growth could be exponential in the near term (1-3 years), supporting double digits, and then some (like higher double digits). I look at XLX as a pretty conservative spec play in the biotech field...Based on the latest spike in price, we could get some good momentum that carries us up over two (too optimistic?) in the near term...